Inhibrx Biosciences Inc (INBX)
14.93
-0.52
(-3.37%)
USD |
NASDAQ |
Nov 14, 12:45
Inhibrx Biosciences Total Assets (Quarterly): 258.42M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 258.42M |
| Date | Value |
|---|---|
| March 31, 2024 | 28.22M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
28.22M
Minimum
Mar 2024
258.42M
Maximum
Jun 2024
143.32M
Average
143.32M
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Protalix BioTherapeutics Inc | 91.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 39.05M |
| Shareholders Equity (Quarterly) | 219.37M |
| Current Ratio | 6.198 |